The term “Ozempic face” has become popular for describing the appearance of the face after weight loss – specifically weight loss that happens after taking Ozempic or similar medication. The ...

What Causes Ozempic Face. Fat loss from the face is “very common with any weight loss,” Silvana Obici, chief of endocrinology and metabolism division at Stony Brook Medicine told Healthline.

Ozempic face is a term coined by Frank to describe how the faces of patients who lose a lot of weight quickly on weight loss medications may become sagging and even look older.

Rapid weight loss while using Ozempic can result in excess skin on the face (and body), creating the appearance of sagging and wrinkles. The medication Ozempic has made news for how it can distort ...

Learn more about "Ozempic face", including what causes it and how facial changes can be treated if desired when using weight loss medications. ‘Ozempic Face’: What It Is And How To Treat It.

What Causes “Ozempic Face”? Patients can use Ozempic as a rapid weight-loss drug. A result of quick weight loss is sagging, aging skin, most noticeably in the face. People with an “Ozempic ...

While some Ozempic faces are appearing older with sunken cheeks, gaunt eyes and sagging neck skin — that doesn’t seem to be the case for Saloman as she’s thrilled with how young her face looks.

Ozempic face is a side effect of taking the diabetes medication. A dermatologist explains what that is, and Oprah and Sharon Osbourne share their thoughts. Skip to main content.

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.

One Ozempic user loves how her face looks after losing weight. Although it’s become so normalized for people to lose weight using GLP-1 — many are suffering from its bizarre side effects, like ...

Surgeons believe that Hollywood is experiencing a spike in the side effect known as “Ozempic Face,” which they claim has affected everyone from John Goodman to Sharon Osbourne.